Still, the shares have shed 42% from their June 2016 highs. Traders have largely been betting against Inovio Pharmaceuticals Inc, with more than …
Myriad Genetics
Out of the six analysts polled in the past 12 months, five rate Inovio stock a Buy, while one rates the stock a …
Inovio Pharmaceuticals Inc
Cannabis stocks are off to a good start in 2017. After gaining 4.2% in January, the MJIC North American Cannabis Stock Index is now up …
North America
HPV affects 300 million women of which 500,000 develop cervical cancer each year. Inovio’s stock price spiked on the deal announcement, and …
HPV
Under a separate equity agreement, ApolloBio will invest in Inovio common stock subsequent to lifting of the …
NASDAQ
Apollobio will invest in Inovio common stock subsequent to lifting of clinical hold * Inovio Pharmaceuticals Inc …
Inovio Pharmaceuticals Inc
The stock is down nearly 2 percent on Year to Date basis while its 12 months gain stands at 8 percent. Inovio was recently in the news for its new Zika treatment GLS-5700. It is developing the treatment in collaboration …
Inovio
Under a separate equity agreement, ApolloBio will invest in Inovio's common stock, once the hold on clinical …
HPV